Inactive Instrument

Other languages Oxford BioMedica plc London S.E.

Equities

HSBC likes Haleon, cuts Flutter to 'hold'	Apr. 18
EARNINGS AND TRADING: Roadside Real Estate trims Cambridge Sleep stake	Mar. 20
Oxford Biomedica Secures New Deal, Expands Existing Agreements for Clinical Programs	Mar. 20
Oxford Biomedica plc Announces Board Changes	Mar. 11
EARNINGS AND TRADING: Harland & Wolff wins major Falklands contract	Mar. 05
Oxford Biomedica plc Provides Earnings Guidance for the Year Ended December 31, 2023 and for the Fiscal Year 2024	Mar. 05
Barclays cuts Bank of Ireland to 'equal weight'	Mar. 05
EnSilica hires new chief financial officer from Oxford Biomedica	Feb. 05
EnSilica Appoints Oxford Biomedica Executive as CFO	Feb. 05
Oxford Biomedica Completes EUR15 Million ABL Europe Acquisition	Jan. 29
Institut Merieux ups stake in Oxford BioMedica toward 10%	Jan. 29
Oxford Biomedica plc completed the acquisition of additional 3.2% stake in ABL EUROPE S.A.S. from TSGH ?6.1 million	Jan. 28
Oxford BioMedica posts optimistic outlook on uptick in contract value	Dec. 07
Oxford Biomedica plc Provides Business Update	Dec. 07
Goldman lifts Landsec and British Land	Dec. 05
Oxford Biomedica to Buy ABL Europe from Institut Mérieux	Dec. 04
Oxford BioMedica buys ABL Europe for consideration of EUR15 million	Dec. 04
Record down as managed assets decline	23-10-20
Citigroup cuts Wizz Air to 'sell'	23-10-18
BoA likes Dowlais; JPMorgan cuts Phoenix Group	23-09-22

No results for this search